Quanterix (QTRX) Stock: Buy, Sell, or Hold?
QTRX - Quanterix Corporation Common Stock
$2.86
0.02 (0.70%)
▲
5d:
-0.35%
30d:
-10.06%
90d:
-22.07%
WAIT
LOW Confidence
Analysis Updated: Oct 23, 2026 12:00 AM ET
Earnings: Nov 09, 2026
15d
Get Alerted When QTRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: QTRX shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: QTRX shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: QTRX is currently trading at $2.86, which is considered oversold relative to its 30-day fair value range of $2.87 to $3.47.
Technical Outlook: Technically, QTRX is in a downtrend. Immediate support is located at $2.67, while resistance sits at $3.35.
Market Sentiment: QTRX scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $3.17 (+10.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, QTRX is in a downtrend. Immediate support is located at $2.67, while resistance sits at $3.35.
Market Sentiment: QTRX scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $3.17 (+10.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.87 -
$3.47
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
93.8%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 0th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($3.17)
- WARNING: Composite score 50/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$2.87 -
$3.47
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$0.27
(9.4%)
Support & Resistance Levels
Support Level
$2.68
Resistance Level
$3.35
Current Trend
Downtrend
Technical data as of
Oct 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.10
Wall Street Target
$3.17
(+10.7%)
Revenue Growth (YoY)
34.4%
Profit Margin
-80.2%
Share & Embed Analysis
Last updated: October 24, 2026 12:04 AM ET
Data refreshes hourly during market hours. Next update: 1:04 AM
Data refreshes hourly during market hours. Next update: 1:04 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is QTRX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
EW
Edwards Lifesciences Corp |
STRONG BUY
29 analysts |
$102 | 58 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
28 analysts |
$121 | 52 HOLD |
|
BSX
Boston Scientific Corp |
STRONG BUY
31 analysts |
$59 | 41 HOLD |
|
MDT
Medtronic PLC |
BUY
29 analysts |
$105 | 38 SELL |
|
AXGN
Axogen Inc |
STRONG BUY
12 analysts |
$54 | 70 BUY |
